Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
ZLAB Quote, Financials, Valuation and Earnings
Last price:
$35.99
Seasonality move
:
-6.9%
Day range:
$35.02 - $35.81
52-week range:
$16.01 - $44.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.62x
P/B ratio:
4.83x
Volume:
271.7K
Avg. volume:
868.5K
1-year change:
90.9%
Market cap:
$3.9B
Revenue:
$399M
EPS (TTM):
-$2.40
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $49M | $144.3M | $215M | $266.7M | $399M | |
| Revenue Growth (YoY) | 277.04% | 194.77% | 49.01% | 24.03% | 49.59% | |
| Cost of Revenues | $16.7M | $52.2M | $74M | $95.8M | $147.9M | |
| Gross Profit | $32.2M | $92.1M | $141M | $170.9M | $251.1M | |
| Gross Profit Margin | 65.82% | 63.8% | 65.58% | 64.08% | 62.94% | |
| R&D Expenses | $222.7M | $573.3M | $286.4M | $265.9M | $234.5M | |
| Selling, General & Admin | $111.3M | $218.8M | $259M | $281.6M | $298.7M | |
| Other Inc / (Exp) | $29.1M | -$9.7M | -$64.8M | -$277K | -$18M | |
| Operating Expenses | $334M | $788M | $533.9M | $545M | $525.1M | |
| Operating Income | -$301.8M | -$696M | -$392.9M | -$374.1M | -$273.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$267.8M | -$703.4M | -$443.1M | -$334.6M | -$257.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$268.9M | -$704.5M | -$443.3M | -$334.6M | -$257.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$268.9M | -$704.5M | -$443.3M | -$334.6M | -$257.1M | |
| Basic EPS (Cont. Ops) | -$3.50 | -$7.60 | -$4.60 | -$3.50 | -$2.60 | |
| Diluted EPS (Cont. Ops) | -$3.50 | -$7.60 | -$4.60 | -$3.50 | -$2.60 | |
| Weighted Average Basic Share | $77.7M | $93M | $95.8M | $96.6M | $98.9M | |
| Weighted Average Diluted Share | $77.7M | $93M | $95.8M | $96.6M | $98.9M | |
| EBITDA | -$263M | -$689.5M | -$434.8M | -$325.6M | -$243M | |
| EBIT | -$267.6M | -$696M | -$443.1M | -$334.6M | -$254.8M | |
| Revenue (Reported) | $49M | $144.3M | $215M | $266.7M | $399M | |
| Operating Income (Reported) | -$301.8M | -$696M | -$392.9M | -$374.1M | -$273.9M | |
| Operating Income (Adjusted) | -$267.6M | -$696M | -$443.1M | -$334.6M | -$254.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.1M | $46.7M | $62.8M | $87.1M | $106.5M | |
| Revenue Growth (YoY) | 144.62% | 132.42% | 34.4% | 38.78% | 22.19% | |
| Cost of Revenues | $7.5M | $15.6M | $21.3M | $33.6M | $38.6M | |
| Gross Profit | $12.6M | $31.1M | $41.5M | $53.5M | $67.8M | |
| Gross Profit Margin | 62.67% | 66.52% | 66.02% | 61.42% | 63.71% | |
| R&D Expenses | $203.9M | $53.9M | $48.5M | $54.6M | $60.7M | |
| Selling, General & Admin | $35.8M | $57M | $62.5M | $69.2M | $63.4M | |
| Other Inc / (Exp) | -$6.2M | -$2.6M | $10.1M | $4.5M | $438K | |
| Operating Expenses | $239.7M | $110.8M | $111M | $121M | $124.1M | |
| Operating Income | -$227.1M | -$79.8M | -$69.5M | -$67.5M | -$56.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$233.1M | -$82.2M | -$49.1M | -$53.5M | -$48.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$232.9M | -$82.4M | -$49.1M | -$53.5M | -$48.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$232.9M | -$82.4M | -$49.1M | -$53.5M | -$48.4M | |
| Basic EPS (Cont. Ops) | -$2.60 | -$0.90 | -$0.50 | -$0.50 | -$0.40 | |
| Diluted EPS (Cont. Ops) | -$2.60 | -$0.90 | -$0.50 | -$0.50 | -$0.40 | |
| Weighted Average Basic Share | $88.4M | $95.5M | $96.1M | $97.3M | $108.1M | |
| Weighted Average Diluted Share | $88.4M | $95.5M | $96.1M | $97.3M | $108.1M | |
| EBITDA | -$225.6M | -$77.8M | -$46.5M | -$50.3M | -$43.8M | |
| EBIT | -$227.1M | -$79.8M | -$49.1M | -$53.4M | -$47.3M | |
| Revenue (Reported) | $20.1M | $46.7M | $62.8M | $87.1M | $106.5M | |
| Operating Income (Reported) | -$227.1M | -$79.8M | -$69.5M | -$67.5M | -$56.3M | |
| Operating Income (Adjusted) | -$227.1M | -$79.8M | -$49.1M | -$53.4M | -$47.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $60.8M | $170.9M | $231.1M | $291.1M | $418.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $22.2M | $60.4M | $79.7M | $108.1M | $152.9M | |
| Gross Profit | $38.7M | $110.6M | $151.4M | $183M | $265.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $392.8M | $423.3M | $281M | $272M | $240.6M | |
| Selling, General & Admin | $128.4M | $240M | $264.5M | $288.3M | $293M | |
| Other Inc / (Exp) | $26M | -$6M | -$52M | -$5.9M | -$22.1M | |
| Operating Expenses | $521.3M | $659.2M | $534M | $555.1M | $528.2M | |
| Operating Income | -$482.6M | -$548.6M | -$382.6M | -$372.1M | -$262.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$453M | -$552.5M | -$410M | -$338.9M | -$252.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$453.8M | -$554M | -$410M | -$338.9M | -$252.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$453.8M | -$554M | -$410M | -$338.9M | -$252.1M | |
| Basic EPS (Cont. Ops) | -$5.43 | -$6.00 | -$4.20 | -$3.50 | -$2.40 | |
| Diluted EPS (Cont. Ops) | -$5.43 | -$6.00 | -$4.20 | -$3.50 | -$2.40 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$441.9M | -$541.6M | -$403.6M | -$329.5M | -$236.4M | |
| EBIT | -$446.9M | -$548.6M | -$412.4M | -$338.8M | -$248.7M | |
| Revenue (Reported) | $60.8M | $170.9M | $231.1M | $291.1M | $418.3M | |
| Operating Income (Reported) | -$482.6M | -$548.6M | -$382.6M | -$372.1M | -$262.7M | |
| Operating Income (Adjusted) | -$446.9M | -$548.6M | -$412.4M | -$338.8M | -$248.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.1M | $46.7M | $62.8M | $87.1M | $106.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.5M | $15.6M | $21.3M | $33.6M | $38.6M | |
| Gross Profit | $12.6M | $31.1M | $41.5M | $53.5M | $67.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $203.9M | $53.9M | $48.5M | $54.6M | $60.7M | |
| Selling, General & Admin | $35.8M | $57M | $62.5M | $69.2M | $63.4M | |
| Other Inc / (Exp) | -$6.2M | -$2.6M | $10.1M | $4.5M | $438K | |
| Operating Expenses | $239.7M | $110.8M | $111M | $121M | $124.1M | |
| Operating Income | -$227.1M | -$79.8M | -$69.5M | -$67.5M | -$56.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$233.1M | -$82.2M | -$49.1M | -$53.5M | -$48.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$232.9M | -$82.4M | -$49.1M | -$53.5M | -$48.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$232.9M | -$82.4M | -$49.1M | -$53.5M | -$48.4M | |
| Basic EPS (Cont. Ops) | -$2.60 | -$0.90 | -$0.50 | -$0.50 | -$0.40 | |
| Diluted EPS (Cont. Ops) | -$2.60 | -$0.90 | -$0.50 | -$0.50 | -$0.40 | |
| Weighted Average Basic Share | $88.4M | $95.5M | $96.1M | $97.3M | $108.1M | |
| Weighted Average Diluted Share | $88.4M | $95.5M | $96.1M | $97.3M | $108.1M | |
| EBITDA | -$225.6M | -$77.8M | -$46.5M | -$50.3M | -$43.8M | |
| EBIT | -$227.1M | -$79.8M | -$49.1M | -$53.4M | -$47.3M | |
| Revenue (Reported) | $20.1M | $46.7M | $62.8M | $87.1M | $106.5M | |
| Operating Income (Reported) | -$227.1M | -$79.8M | -$69.5M | -$67.5M | -$56.3M | |
| Operating Income (Adjusted) | -$227.1M | -$79.8M | -$49.1M | -$53.4M | -$47.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $442.1M | $964.1M | $1B | $790.2M | $449.7M | |
| Short Term Investments | $744.7M | $445M | -- | $16.3M | $330M | |
| Accounts Receivable, Net | $5.2M | $47.5M | $40M | $59.2M | $85.2M | |
| Inventory | $13.1M | $19M | $31.6M | $44.8M | $39.9M | |
| Prepaid Expenses | $10.9M | -- | -- | -- | -- | |
| Other Current Assets | -- | $18M | $35.7M | $23M | $41.5M | |
| Total Current Assets | $1.2B | $1.5B | $1.1B | $939.6M | $1.1B | |
| Property Plant And Equipment | $47.1M | $58.3M | $78.8M | $68.7M | $69.5M | |
| Long-Term Investments | $1.3M | $15.6M | $6.4M | $9.2M | $3.1M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $9.4M | $9.7M | $8.4M | $16.5M | $58.9M | |
| Other Long-Term Assets | $743K | $803K | $803K | $1.1M | $1.1M | |
| Total Assets | $1.3B | $1.6B | $1.2B | $1B | $1.2B | |
| Accounts Payable | $62.6M | $126.2M | $66M | $113M | $100.9M | |
| Accrued Expenses | $23.9M | $45M | $44.2M | $58.2M | $46.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $5.2M | $5.9M | $7.1M | $7.1M | $8M | |
| Other Current Liabilities | $4.6M | $4.4M | $4.1M | $5.4M | $6.4M | |
| Total Current Liabilities | $98M | $192.9M | $139.8M | $203.1M | $299.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $128.3M | $230M | $174.5M | $240.2M | $344.9M | |
| Common Stock | $5K | $6K | $6K | $6K | $7K | |
| Other Common Equity Adj | -$14.5M | -$23.6M | $25.7M | $37.6M | $50.5M | |
| Common Equity | $1.2B | $1.4B | $1B | $796.1M | $840.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.2B | $1.4B | $1B | $796.1M | $840.9M | |
| Total Liabilities and Equity | $1.3B | $1.6B | $1.2B | $1B | $1.2B | |
| Cash and Short Terms | $1.2B | $1.4B | $1B | $806.5M | $779.7M | |
| Total Debt | -- | -- | -- | -- | $131.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1B | $847M | $879.8M | $650.8M | $757.3M | |
| Short Term Investments | -- | $465.3M | $50.6M | -- | -- | |
| Accounts Receivable, Net | $8.8M | $33.4M | $43.3M | $60.4M | $76.6M | |
| Inventory | $12.6M | $20.3M | $38.4M | $37.9M | $53.1M | |
| Prepaid Expenses | $14.3M | $16.5M | -- | -- | -- | |
| Other Current Assets | -- | -- | $42.8M | $24.2M | $43.9M | |
| Total Current Assets | $1B | $1.4B | $1.1B | $888.6M | $1B | |
| Property Plant And Equipment | $45.9M | $67.2M | $80.2M | $67.7M | $68.7M | |
| Long-Term Investments | $1.5M | $8.4M | $6.9M | $14.1M | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $9.4M | $9.5M | $8.4M | $15.4M | $59.1M | |
| Other Long-Term Assets | $743K | $803K | $1M | $1.1M | $3.6M | |
| Total Assets | $1.1B | $1.5B | $1.2B | $988.4M | $1.2B | |
| Accounts Payable | $41.4M | $98.2M | $66.4M | $88.1M | $103M | |
| Accrued Expenses | $34.1M | $36.1M | $30.2M | $36M | $27.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $48.3M | -- | |
| Current Portion Of Capital Lease Obligations | $5.6M | $6.8M | $7.3M | $7.5M | $6.6M | |
| Other Current Liabilities | $7.8M | $3.2M | $3.5M | $2.8M | $3M | |
| Total Current Liabilities | $92.7M | $154.9M | $124.6M | $192.1M | $319.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $121.6M | $192.9M | $168.8M | $226.3M | $362.6M | |
| Common Stock | $5K | $6K | $6K | $6K | $7K | |
| Other Common Equity Adj | -$11.6M | -$25.8M | $17.3M | $39.2M | $49.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1B | $1.3B | $1B | $762.2M | $810.8M | |
| Total Liabilities and Equity | $1.1B | $1.5B | $1.2B | $988.4M | $1.2B | |
| Cash and Short Terms | $1B | $1.3B | $930.4M | $650.8M | $757.3M | |
| Total Debt | -- | -- | -- | $48.3M | $173.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$268.9M | -$704.5M | -$443.3M | -$334.6M | -$257.1M | |
| Depreciation & Amoritzation | $4.6M | $6.5M | $8.2M | $9M | $11.9M | |
| Stock-Based Compensation | $24.8M | $40.7M | $61.3M | $79.6M | $70.7M | |
| Change in Accounts Receivable | -$9.8M | -$51.4M | $25.1M | -$17.7M | -$26.6M | |
| Change in Inventories | -$7.2M | -$7.2M | -$15.4M | -$14.9M | $3.9M | |
| Cash From Operations | -$216.1M | -$549.2M | -$367.6M | -$198.2M | -$214.9M | |
| Capital Expenditures | $10.7M | $18.9M | $25M | $8.5M | $61.5M | |
| Cash Acquisitions | -- | -$30M | -- | -- | -- | |
| Cash From Investing | -$554.8M | $250M | $420M | -$10.8M | -$375.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $131.6M | |
| Long-Term Debt Repaid | -$6.5M | -- | -- | -- | -$284K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.4M | -$6.1M | -$7.6M | -$8.8M | -$2M | |
| Cash From Financing | $1.1B | $820.2M | -$1.7M | -$6.4M | $349.9M | |
| Beginning Cash (CF) | $76.4M | $442.9M | $964.9M | $1B | $791.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $361.6M | $520.9M | $50.6M | -$215.4M | -$240.2M | |
| Ending Cash (CF) | $442.9M | $964.9M | $1B | $791.3M | $550.8M | |
| Levered Free Cash Flow | -$226.7M | -$568.2M | -$392.6M | -$206.7M | -$276.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$232.9M | -$82.4M | -$49.1M | -$53.5M | -$48.4M | |
| Depreciation & Amoritzation | $1.4M | $2M | $2.7M | $3M | $3.5M | |
| Stock-Based Compensation | $7.3M | $12.4M | $16.7M | $18M | $15.8M | |
| Change in Accounts Receivable | -$5.2M | $13.7M | -$11.5M | -$10.6M | $1.9M | |
| Change in Inventories | $502K | -$1.5M | -$6.7M | $6.8M | -$13.2M | |
| Cash From Operations | -$169.5M | -$87.1M | -$69.3M | -$90.1M | -$61.7M | |
| Capital Expenditures | $1.9M | $9.9M | $3.5M | $13M | $3.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $742M | -$30.1M | -$54M | $3.3M | $326.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $48.2M | $101.9M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$60.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$973K | -$39K | -$5.1M | -$700K | -$854K | |
| Cash From Financing | -$271K | $258K | -$3.9M | $47.5M | $43.1M | |
| Beginning Cash (CF) | $442.9M | $964.9M | $1B | $791.3M | $550.8M | |
| Foreign Exchange Rate Adjustment | -$930K | -$130K | -$1.3M | -$104K | $20K | |
| Additions / Reductions | $572.2M | -$117M | -$127.1M | -$39.3M | $307.6M | |
| Ending Cash (CF) | $1B | $847.8M | $880.8M | $751.9M | $858.4M | |
| Levered Free Cash Flow | -$171.4M | -$97M | -$72.8M | -$103.1M | -$65.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$453.8M | -$554M | -$410M | -$338.9M | -$252.1M | |
| Depreciation & Amoritzation | $5M | $7.1M | $8.9M | $9.4M | $12.3M | |
| Stock-Based Compensation | $25.7M | $45.8M | $65.6M | $81M | $68.5M | |
| Change in Accounts Receivable | -$13.5M | -$32.5M | $25K | -$16.8M | -$14.2M | |
| Change in Inventories | -$6.6M | -$9.2M | -$20.6M | -$1.4M | -$16.1M | |
| Cash From Operations | -$345.7M | -$466.9M | -$349.8M | -$219M | -$186.5M | |
| Capital Expenditures | $11.5M | $26.9M | $18.6M | $18M | $52.4M | |
| Cash Acquisitions | -- | -$30M | -- | -- | -- | |
| Cash From Investing | $138.2M | -$522.2M | $396.2M | $46.5M | -$52.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $48.2M | $185.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.6M | -$5.2M | -$12.6M | -$4.4M | -$2.1M | |
| Cash From Financing | $852.7M | $820.7M | -$5.9M | $45M | $345.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $645.2M | -$168.3M | $40.5M | -$127.5M | $106.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$357.2M | -$493.8M | -$368.4M | -$237M | -$238.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$232.9M | -$82.4M | -$49.1M | -$53.5M | -$48.4M | |
| Depreciation & Amoritzation | $1.4M | $2M | $2.7M | $3M | $3.5M | |
| Stock-Based Compensation | $7.3M | $12.4M | $16.7M | $18M | $15.8M | |
| Change in Accounts Receivable | -$5.2M | $13.7M | -$11.5M | -$10.6M | $1.9M | |
| Change in Inventories | $502K | -$1.5M | -$6.7M | $6.8M | -$13.2M | |
| Cash From Operations | -$169.5M | -$87.1M | -$69.3M | -$90.1M | -$61.7M | |
| Capital Expenditures | $1.9M | $9.9M | $3.5M | $13M | $3.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $742M | -$30.1M | -$54M | $3.3M | $326.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $48.2M | $101.9M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$60.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$973K | -$39K | -$5.1M | -$700K | -$854K | |
| Cash From Financing | -$271K | $258K | -$3.9M | $47.5M | $43.1M | |
| Beginning Cash (CF) | $442.9M | $964.9M | $1B | $791.3M | $550.8M | |
| Foreign Exchange Rate Adjustment | -$930K | -$130K | -$1.3M | -$104K | $20K | |
| Additions / Reductions | $572.2M | -$117M | -$127.1M | -$39.3M | $307.6M | |
| Ending Cash (CF) | $1B | $847.8M | $880.8M | $751.9M | $858.4M | |
| Levered Free Cash Flow | -$171.4M | -$97M | -$72.8M | -$103.1M | -$65.6M | |
Get ZLAB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ZLAB
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
4.83x
1.80x
Price / LTM sales
8.62x
1.65x
Growth Metrics
ZLAB
Sector
Revenue growth
22.19%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
98.38%
8.01%
Earnings forecast
-$0.42
-$0.20
Profitability
ZLAB
Sector
Profitability FY 2024
$251.1M
$47.5M
Return on invested capital
-29.16%
-16.26%
Return on assets
-23.69%
-13.27%
Return on equity
-33.29%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
7
Balance Sheet
ZLAB
Sector
Total cash
$757.3M
$35.5M
Short term investments
$330M
$29.7M
Total assets
$1.2B
$106.9M
Long term debt
$173.4M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
